Fj. Ekinci et Tb. Shea, SELECTIVE ACTIVATION BY BRYOSTATIN-1 DEMONSTRATES UNIQUE ROLES FOR PKC-EPSILON IN NEURITE EXTENSION AND TAU-PHOSPHORYLATION, International journal of developmental neuroscience, 15(7), 1997, pp. 867-874
Phorbol esters such as 12-O-tetradeonyl phorbol-13 acetate (TPA) induc
e a time-dependent biphasic effect on protein kinase C (PKC)-mediated
events by fostering translocation of cytosolic (latent) PKC to the pla
sma membrane (where it is activated). Continued treatment, however, de
pletes the cell's entire PKC complement and induces a functional stake
of PKC inhibition. Previous studies from several laboratories have de
monstrated that long-term TPA treatment, like treatment with PKC inhib
itors, induces neuronal differentiation. Bryostatin-l also induces tra
nslocation and overall downregulation of PKC following long-term treat
ment, yet, unlike TPA or PKC inhibitors, does not induce neuronal diff
erentiation, promoting controversy regarding the role of PKC inhibitio
n in neuronal differentiation. We demonstrate herein that, despite ove
rall downregulation in human neuroblastoma cells, membrane-associated
levels of one PKC isoform (PKC epsilon) are actually increased followi
ng long-term bryostatin-l treatment. Since previous studies have impli
cated this PKC isoform in phosphorylation of the microtubule-associate
d protein tau and in neuritogenesis, we examined the consequences of l
ong-term bryostatin treatment on these phenomena. Treatment with 25 n-
100 Icl bryostatin-l for 72 h increased tau phosphorylation and inhibi
ted neuritogenesis, By contrast, treatment with either TPA or the PKC
inhibitor staurosporine did not induce tau phosphorylation and induced
neurite elaboration. Bryostatin-l antagonized neurite induction by st
aurosporine. These findings provide additional evidence for a unique r
ole of PKC epsilon in the regulation of tan phosphorylation and neuron
al differentiation,, and demonstrate that bryostatin-l can function un
der cel tain conditions as a selective PKC epsilon activator even foll
owing long-term treatment. (C) 1997 Published by Elsevier Science Ltd
on behalf of ISDN.